Key result
Norovirus infection was detected at a significantly higher rate among symptomatic neonates (37.2%) compared to asymptomatic controls (14.1%).
Why the study?
Does genogroup II norovirus infection increase the risk of gastrointestinal symptoms in neonates?
Case-Control (n=309)
No
Does genogroup II norovirus infection increase the risk of gastrointestinal symptoms in neonates?
Absolute Event Rate: 37.2% vs 14.1%
p-value: p=<0.001
Genogroup IIb norovirus is highly prevalent in neonates and significantly associated with gastrointestinal symptoms, with rotavirus coinfection potentially exacerbating disease severity.
Norovirus may contribute to neonatal GI symptoms; hypothesis-generating and should not yet change testing or management.
Noroviruses (NoVs) are increasingly recognized as an important cause of acute gastroenteritis in children worldwide. However, there are limited data on the role of NoVs in neonatal infections and disease. The objectives of the present study were to determine the prevalence of NoVs in neonates with gastrointestinal disease using a case-control study design and to characterize the NoV strains infecting neonates. A total of 309 fecal samples from 161 neonates with gastrointestinal symptoms and 148 asymptomatic controls were screened for genogroup II (GII) NoV using reverse transcription-PCR. A subset of PCR-positive amplicons for the polymerase and capsid regions was sequenced. NoV was detected in 26.2% of samples, with the rate of detection being significantly higher among symptomatic neonates (60/161, 37.2%) than asymptomatic neonates (24/148, 14.1%) (P < 0.001). On the basis of sequencing of 29 strains, a single NoV strain, GIIb, was identified to be the predominant (27/29, 93.1%) cause of neonatal infections. Coinfection with rotavirus was seen in nearly one-third of symptomatic neonates. The study demonstrates a high prevalence of NoV infections in neonates and indicates that coinfection with rotavirus may result in significantly more gastrointestinal disease in this population.
No takes yet. Share an insight, caveat, or question.
Menon et al. (2010) conducted a case-control in Gastrointestinal symptoms (n=309). Gastrointestinal symptoms vs. Asymptomatic controls was evaluated on Detection of Norovirus (GII) (p=<0.001). Norovirus infection was detected at a significantly higher rate among symptomatic neonates (37.2%) compared to asymptomatic controls (14.1%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: